Hospital de Antequera

The Hospital de Antequera is conducting a maternal immunization study with the GBS6 vaccine to evaluate safety and to generate protective antibodies that may prevent early‑onset and late‑onset Group B streptococcus disease in newborns.

• Maternal vaccine safety assessment
• Infant antibody level monitoring
• Prevention of invasive GBS infections

This research contributes to the site’s portfolio of four clinical trials led by seven investigators, emphasizing the fight against bacterial infections.

Researchers in the internal medicine department are evaluating new therapies to lower the risk of cardiovascular death, heart failure events, and stroke in patients with hypertension and established heart disease, including the impact on major adverse cardiovascular events.

• Reduction of cardiovascular mortality
• Blood pressure management in high‑risk groups
• Investigation of novel RNA‑based treatment

The trials reflect a focused effort to improve outcomes for patients with cardiovascular conditions across Europe.

A study targeting individuals with heart failure with preserved ejection fraction (HFpEF) and obesity is testing a weekly investigational therapy added to standard care, aiming to reduce hospitalisations and improve metabolic health.

• Influence of obesity on heart failure progression
• Weekly treatment efficacy alongside standard therapy
• Assessment of metabolic parameters in cardiac patients

This work underscores the site’s commitment to addressing the interplay between metabolic disorders and cardiovascular risk.